Joshua J Skydel
Biographic Data
| ID | 8450452 |
|---|---|
| NAME | Joshua J Skydel |
| GIVEN NAMES | Joshua J |
| FAMILY NAME | Skydel |
| SIGNATURE | SKYDEL J J |
| AFFILIATIONS | Dartmouth–Hitchcock Medical Center |
| ORCID | 0000-0002-3527-4277 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
The findings of this cross-sectional study indicate that most of the drugs granted FDA accelerated approval for original indications from 2012 to 2017 lacked confirmatory trials evaluating clinical outcomes to support conversion to standard approval. Automatic coverage mandates produced substantial CMS spending for drugs with unproven clinical benefits
No prominent works on this page.
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
The findings of this cross-sectional study indicate that most of the drugs granted FDA accelerated approval for original indications from 2012 to 2017 lacked confirmatory trials evaluating clinical outcomes to support conversion to standard approval. Automatic coverage mandates produced substantial CMS spending for drugs with unproven clinical benefits
Authorization (1 work) · Clinical trial (1 work) · Drug (1 work) · Drug approval (1 work) · Environmental health (1 work) · Family medicine (1 work) · Food and drug administration (1 work) · Health care (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Internal Medicine (1 work)